XJXin Jin

Xin Jin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xin Jin has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Huifang Jiang

    Department of Hematology Tongde Hospital of Zhejiang Province Hangzhou China

    3 shared publications
  • Wenfei Zhou

    Department of Hematology Tongde Hospital of Zhejiang Province Hangzhou China

    3 shared publications
  • Zhilu Chen

    Department of Hematology Tongde Hospital of Zhejiang Province Hangzhou China

    3 shared publications
  • Chuan Su

    Affiliation Key Laboratory for Pathogen Infection and Control of Jiangsu Province, Department of Pathogen Biology and Immunology, School of Basic Medical Sciences, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, Jiangsu, China

    2 shared publications
  • Jifeng Zhu

    Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, China

    2 shared publications
  • Lei Xu

    Machine Intelligence Laboratory, College of Computer Science, Sichuan University, No. 24 South Section 1, Yihuan Road, Chengdu 610065, China

    2 shared publications

Latest Publications

  • Open Access

    Establishing Reference Intervals for Adult Lymphocyte Subsets: Single‐Platform Volume Analysis Reveals Age‐ and Sex‐Specific Trajectories of Immunosenescence

    by Linjuan Yao, Hui Fang, Shibo He, Jianchao Wang, Xin Jin

    Background: Current clinical reference intervals for lymphocyte subsets lack age‐ and sex‐specific stratification, limiting accurate immune assessment. This study aimed to establish such stratified reference intervals in a large cohort of healthy adults aged 20–60 years. Methods: A total of 1760 healthy adults were included. The absolute counts and percentage distributions of peripheral blood (PB) lymphocyte subsets were determined via flow cytometry (FCM) using a single‐platform volume method. Differences between age groups and sexes were then compared. Results: The absolute counts of total T cells and CD8 + T cells decreased with advancing age, whereas the absolute counts of CD4 + T cells remained relatively stable, although their percentage increased with age. There was a significant difference in immunological age between the 20–40‐year‐old and 41–60‐year‐old groups. Concurrently, the results of this study revealed immunological sexual dimorphism; however, this disparity tended to diminish in the 51–60‐year‐old group because of changes in female sex hormones. Conclusion: This study established refined reference intervals for adult lymphocyte subsets. The physiological ageing of the immune system constitutes a nonlinear dynamic process, and the establishment of two‐dimensional reference intervals based on both sex and age is recommended.

  • Immunophenotypic Characterization of Neoplastic T Follicular Helper Cells by Flow Cytometry

    by Xin Jin, Zhilu Chen, Qing Pan, Shuyuan Tian, Yuxia Jiang, Chuanyong Su, Wenfei Zhou, Huifang Jiang

    Background: T follicular helper (TFH) cell lymphoma is complex, and we hope to provide a new perspective for its diagnosis. Methods: We analysed the immunophenotypes of 89 mature T‐cell lymphomas, including 52 nodal lymphomas of TFH origin, as well as 32 benign lymph node samples and 30 healthy bone marrow samples, by flow cytometry (FCM). Results: Among pan‐T cell markers, CD4 + CD5 + CD3 − is the typical pattern that distinguishes TFH lymphoma from other T‐cell lymphomas. Specific markers with high sensitivity for the diagnosis of TFH lymphoma include programmed cell death protein 1 (PD‐1) and inducible synergistic co‐stimulation molecules (ICOS), which are expressed at lower levels in neoplastic TFH cells than in benign TFH cells. In contrast, the specificity of C‐X‐C chemokine receptor type 5 (CXCR5) and CD10 is high, and the proportion of CD10‐positive cells in neoplastic TFH samples is greater than that in benign TFH samples. Of the 52 TFH lymphoma samples in our study, 7 presented with abnormalities in B cells or plasmablast cells; we considered these to indicate B‐cell proliferation rather than composite lymphoma. Conclusion: Immunophenotypic characterization of neoplastic TFH cells by FCM is unique and has diagnostic value. Each specimen of suspected TFH lymphoma should be analyzed for the presence of specific markers, such as PD‐1, ICOS, CXCR5, and CD10, and the clonality of B cells and plasmablast cells should be assessed.


  • Open Access

    Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus

    by Zhuangyuan Tang, Shuo Wang, Xi Li, Chengbin Hu, Qiangrong Zhai, Jing Wang, Qingshi Ye, Jinnan Liu, Guohong Zhang, Yuanyuan Guo, et al.


  • Analysis of flow cytometry data from ultrasound‐guided lymph node biopsies with two types of needles

    by Xin Jin, Huifang Jiang, Yuxia Jiang, Zhilu Chen, Wenfei Zhou, Qing Pan, Shuyuan Tian

    Background: In this study, we combined two techniques, ultrasound‐guided needle biopsy and flow cytometry (FCM), to explore their value in patients with enlarged lymph nodes. Methods: We compared the results of 198 needle biopsies on FCM and pathology. Forty‐two were done by (fine needle aspiration, FNA), and the remaining 156 with (core needle biopsy, CNB), in 36 of 156 patients, a FNA was performed in the same lymph node after completion of the CNB. Except for five types of pathological entities, the rest were differentiated only detected or undetected tumours as the outcome distinction. Results: Among the 198 needle biopsies, 13 were inadequate specimens, while the remaining 185 had pathological findings, including 47 benign and 138 neoplastic findings. Thirty‐six patients underwent puncture with both FNA and CNB, both needles produced identical results by FCM, but more cells were obtained by FNA. Among the pathologically positive results, there were 23 missed diagnoses in FCM, in contrast, evidence of tumours was observed in the FCM images of 15 needle biopsies that reported benign or findings that were inconsistent with pathology, and the final diagnosis was consistent with the FCM in 10 cases. FCM detected haematolymphoid tumours with a sensitivity of 87.8% and a specificity of 91.9%. Conclusion: The combination of FCM and ultrasound‐guided lymph node needle biopsy can quickly provide guidance for clinical decision‐making. We recommend that all lymph node needle biopsies be sent for FCM, the specimen can be obtained by the last puncture with FNA.


  • Open Access

    IL-4 as a potential biomarker for differentiating major depressive disorder from bipolar depression

    by Lingna Mm Lu, Xiwen Mm Hu, Xin Mm Jin

    We aimed to investigate the differential diagnosis of depressive episodes in patients with major depressive disorder (MDD) and bipolar disorder (BD) using peripheral blood cytokine expression levels. The levels of interleukin (IL)-2, IL-6, IL-10, IL-17, IL4, and IL-12; interferon (IFN)-γ; and tumor necrosis factor (TNF)-α were measured in patients with MDD and BD presenting acute episodes in an inpatient psychiatric setting. The expression levels of IL-6, IL-10, IL-17, and IFN-γ in the MDD and BD groups were higher than those in the control group (P < .05), but there was no significant difference between the patient groups and control group. Only the expression levels of TNF-α and IL-4 were higher in both groups than in the control group, and the BD group had higher levels than the MDD group (P < .05). The expression levels of IL-17, IFN-γ, IL-10, and IL-4 were significantly higher in BD-related manic episodes than in BD-related depressive episodes (P < .05). IL-6, IFN-γ, TNF-α, IL-10, and IL-4 levels were higher in BD-related depressive episodes than in MDD-related depressive episodes (P < .05). The receiver operating characteristic curve test for MDD and BD and the area under the curve for IL-4 revealed good clinical predictability. Patients with MDD and BD exhibited different cytokine profiles when experiencing acute episodes; patients with BD exhibited a more severe immune-inflammatory response system–compensatory immunoregulatory response system (CIRS) imbalance. IL-4 was found to have diagnostic value in differentiating between active depressive episodes in MDD and BD.


  • Open Access

    Effects of Sodium Chlorophyllin Copper on APO-1 Expression in Bone Marrow Mesenchymal Stem Cells of Rats with Aplastic Anaemia

    by Xin Jin, Guanhai Dai, Liyang Xuan, Meng Zhang, Huifang Jiang, Yang Sui

    Background. Aplastic anaemia (AA) is a highly prevalent blood disorder in the East and Southeast Asian countries, and a proportion of the patients is poorly treated with immunosuppressive agents. This study is aimed at exploring the effects of sodium copper chlorophyllin (SCC) on rats with AA and at providing the theoretical basis for the treatment of AA using traditional Chinese medicine. Methods. A rat model of AA was induced by combining 5-fluorouracil with busulfan, and different groups were treated with 25mg/kg cyclosporin A (CsA) and low-, medium-, and high-dose SCC (25-, 50-, and 100-mg/kg; L-, M-, and H-SCC, respectively). A comparative analysis of peripheral blood counts, T-cell subsets, cytokine levels, bone marrow pathology, and APO-1 expression in mesenchymal stem cells in each group was conducted. Results. SCC can increase the platelet count and haemoglobin concentration in the peripheral blood of AA rats, whereas bone marrow biopsies revealed that the number of nucleated cells and megakaryocytes of SCC-treated rats increased compared with the model group. This was particularly evident in the H-SCC group. As regards the correction of immune function, unlike CsA, which reduced the absolute CD8+ T-cell count, SCC corrected the imbalanced CD4/CD8 ratio by increasing the absolute CD4+ T-cell count, whereas SCC increased the number of regulatory T-cells and reduced the level of interferon-γ in AA rats. When comparing the expression of APO-1 in the MSCs, results of the reverse-transcriptase polymerase chain reaction and Western blot analysis showed that SCC can increase the expression of APO-1 both at the mRNA and protein levels. Conclusion. We found that SCC can improve haematopoietic function and regress immune disorders in AA rats, which enhanced the expression of APO-1 in bone marrow MSCs. This may be one of the mechanisms of SCC in treating AA.


  • A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China

    by Lianzhong Wu, Jin Lai, Yixin Ling, Yiqin Weng, Shujuan Zhou, Siqi Wu, Songfu Jiang, Xiaokai Ding, Xin Jin, Kang Yu, et al.

    A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China - Article abstract #930097


  • Open Access

    Blockade of PD-1 Signaling Enhances Th2 Cell Responses and Aggravates Liver Immunopathology in Mice with Schistosomiasis japonica

    by Sha Zhou, Xin Jin, Yalin Li, Wei Li, Xiaojun Chen, Lei Xu, Jifeng Zhu, Zhipeng Xu, Yang Zhang, Feng Liu, et al.

    More than 220 million people worldwide are chronically infected with schistosomes, causing severe disease or even death. The major pathological damage occurring in schistosomiasis is attributable to the granulomatous inflammatory response and liver fibrosis induced by schistosome eggs. The inflammatory response is tightly controlled and parallels immunosuppressive regulation, constantly maintaining immune homeostasis and limiting excessive immunopathologic damage in important host organs. It is well known that the activation of programmed death 1 (PD-1) signaling causes a significant suppression of T cell function. However, the roles of PD-1 signaling in modulating CD4+ T cell responses and immunopathology during schistosome infection, have yet to be defined. Here, we show that PD-1 is upregulated in CD4+ T cells in Schistosoma japonicum (S. japonicum)-infected patients. We also show the upregulation of PD-1 expression in CD4+ T cells in the spleens, mesenteric lymph nodes, and livers of mice with S. japonicum infection. Finally, we found that the blockade of PD-1 signaling enhanced CD4+ T helper 2 (Th2) cell responses and led to more severe liver immunopathology in mice with S. japonicum infection, without a reduction of egg production or deposition in the host liver. Overall, our study suggests that PD-1 signaling is specifically induced to control Th2-associated inflammatory responses during schistosome infection and is beneficial to the development of PD-1-based control of liver immunopathology. Schistosomiasis is a parasitic disease that affects approximately 220 million people and causes serious morbidity and economic problems mainly in (sub)tropical regions. After Schistosoma japonicum or Schistosoma mansoni infection, parasite eggs are trapped in host liver and induce liver inflammation and fibrosis, leading to irreversible impairment of the liver, and even death of the host. Meanwhile, schistosomes also induce strong regulatory mechanisms to suppress inflammation and prevent excessive immunopathology. Considering it is well known that PD-1 plays a critical role in suppressing T cell function, understanding the role of PD-1 in modulating immune responses during schistosome infection is necessary for the development of PD-1-based control of liver damage in schistosomiasis. Here, increased PD-1 expression in CD4+ T cells from both humans and mice with schistosome infection was shown. We further showed that PD-1 blockade preferentially augmented Th2 cell responses and ultimately resulted in more severe liver immunopathology in mice with Schistosomiasis japonica, suggesting that PD-1 signaling is beneficial to further explore therapeutic possibilities for preventing the excessive liver immunopathology.


  • Open Access

    Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica

    by Xiaojun Chen, Wei Li, Yang Zhang, Xian Song, Lei Xu, Zhipeng Xu, Sha Zhou, Jifeng Zhu, Xin Jin, Feng Liu, et al.

    Schistosomiasis is a helminthic disease that affects more than 200 million people. An effective vaccine would be a major step towards eliminating the disease. Studies suggest that T follicular helper (Tfh) cells provide help to B cells to generate the long-term humoral immunity, which would be a crucial component of successful vaccines. Thus, understanding the biological characteristics of Tfh cells in patients with schistosomiasis, which has never been explored, is essential for vaccine design. In this study, we investigated the biological characteristics of peripheral memory Tfh cells in schistosomiasis patients by flow cytometry. Our data showed that the frequencies of total and activated peripheral memory Tfh cells in patients were significantly increased during Schistosoma japonicum infection. Moreover, Tfh2 cells, which were reported to be a specific subpopulation to facilitate the generation of protective antibodies, were increased more greatly than other subpopulations of total peripheral memory Tfh cells in patients with schistosomiasis japonica. More importantly, our result showed significant correlations of the percentage of Tfh2 cells with both the frequency of plasma cells and the level of IgG antibody. In addition, our results showed that the percentage of T follicular regulatory (Tfr) cells was also increased in patients with schistosomiasis. Our report is the first characterization of peripheral memory Tfh cells in schistosomasis patients, which not only provides potential targets to improve immune response to vaccination, but also is important for the development of vaccination strategies to control schistosomiasis. Schistosomiasis affects more than 200 million people worldwide and causes more than 280,000 deaths per year. Current control strategies are based on chemotherapy, but recurrent reinfection of people living in endemic areas makes researchers search for an effective vaccine to provide long-term protection against schistosomiasis. The generation of long-lived high-affinity antibodies after vaccination is a pivotal step for anti-schistosome vaccine to eliminate schistosomiasis. Considering it is well-known that Tfh cells are specialized effector CD4+ T cells that provide help for germinal center (GC) formation and induce GC B cells to develop protective antibody responses, understanding the biology of Tfh cells in schistosomiasis patients is fundamental for vaccine strategy development. Here, for the first time, we documented increased frequencies of total and activated peripheral memory Tfh cells in schistosomiasis patients. Furthermore, we showed that Tfh2 cells were a major contributor to increased frequency of peripheral memory Tfh cells in patients with schistosomiasis japonica. More importantly, we found the significant correlations of the percentage of Tfh2 cells with both the frequency of plasma cells and the level of total IgG antibody in schistosomiasis patients.